evenfolioETF Details
Global X Funds·Health·GNOM · Nasdaq
Global X Genomics & Biotechnology ETF (GNOM)
- Price
- $69.61
- —30 Oct 2026
- Assets
- $102.9M
- Total net assets
- Expense ratio
- 0.50%
- Category 1.00%
- Yield
- 0.92%
- Trailing distributions
- 1Y return
- 58.8%+30.0%
- Category 28.8%
- 3Y CAGR
- 25.8%+4.2%
- Category 21.5%
- 5Y CAGR
- -3.8%-7.9%
- Category 4.1%
Loading NAV history…
Global X Genomics & Biotechnology ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | -1.2% | +28.5% | +53.4% | +53.3% | +58.8% | +25.8% | -3.8% | — | +1.9% |
| Health average | 3.6% | 9.9% | 23.0% | 20.4% | 28.8% | 21.5% | 4.1% | 10.8% | 11.6% |
| Difference | -4.8% | +18.6% | +30.4% | +32.9% | +30.0% | +4.2% | -7.9% | — | -9.8% |
Holdings
The 10 largest positions make up 55.7% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| MRNA | Moderna Inc | 9.45% |
| TWST | Twist Bioscience Corp | 8.10% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 7.28% |
| ILMN | Illumina Inc | 5.72% |
| GH | Guardant Health Inc | 5.43% |
| NTRA | Natera Inc | 5.43% |
| 1548.HK | Genscript Biotech Corp Class H | 4.63% |
| TECH | Bio-Techne Corp | 3.38% |
| VRTX | Vertex Pharmaceuticals Inc | 3.26% |
| BMRN | BioMarin Pharmaceutical Inc | 3.02% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- —
- P/B
- 4.6
- P/S
- 8.0
- P/CF
- 27.3
Sector allocation
Share of the equity the fund holds.
- Health care99.7%
- Technology0.3%
Asset mix
- Stocks100.0%
ETF details
- Issuer
- Global X Funds
- Category
- Equity · Health
- Ticker
- GNOM
- Exchange
- Nasdaq
- Inception
- 5 Apr 2019 (7.6 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.50% (category 1.00%)
- Holdings turnover
- 34% (category 51%)
- Distribution yield
- 0.92%
- Beta, 3 years
- 1.53
- Total net assets
- $102.9M
Prices and returns as of 30 Oct 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- AGNG · Global X Aging Population ETFGlobal X Funds · $88.9M · ER 0.50%5Y 6.8%
- HTEC · ROBO Global Healthcare Technology and Innovation ETFRobo Global · $76.3M · ER 0.68%5Y -0.3%
- OZEM · Roundhill GLP-1 & Weight Loss ETFRoundhill Investments · $57.8M · ER 0.59%
- HRTS · Tema Heart & Health ETFTema ETFs · $53.7M · ER 0.75%
- FMED · Fidelity Disruptive Medicine ETFFidelity Investments · $52.3M · ER 0.50%
- BBC · Virtus Biotech Clinical Trials ETFVirtus · $43.8M · ER 0.65%5Y 0.0%